Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GALR Inhibitors

Santa Cruz Biotechnology now offers a broad range of GALR Inhibitors for use in various applications. Galanin receptors (GALRs) are a group of G-protein coupled receptors, including GALR1, GALR2, and GALR3, that play a critical role in modulating a variety of physiological processes such as neurotransmission, mood regulation, pain perception, and hormone secretion. These receptors are activated by the neuropeptide galanin, which influences several key functions within the central and peripheral nervous systems. GALR Inhibitors are essential tools in scientific research, allowing researchers to explore the mechanisms by which these receptors contribute to physiological and neurological processes. By inhibiting GALRs, scientists can investigate the specific roles of each receptor subtype in various biological contexts, helping to unravel the complex pathways involved in mood disorders, neurodegenerative diseases, and metabolic conditions. These inhibitors are widely used in neurobiological research, pharmacological studies, and behavioral experiments to understand the effects of blocking galanin signaling and its implications for disease mechanisms. Additionally, GALR Inhibitors are valuable for exploring the intricate dynamics between galanin receptors and other signaling pathways. The availability of these inhibitors has significantly advanced research in fields such as neuroscience and endocrinology, providing crucial tools for studying the regulation and function of galanin receptors. View detailed information on our available GALR Inhibitors by clicking on the product name.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

M35

142846-71-7sc-391348
sc-391348A
0.5 mg
1 mg
$214.00
$362.00
(0)

M35 functions as a potent galr inhibitor by selectively disrupting the interaction between galanin and its receptors. Its unique structure allows for competitive binding, effectively blocking receptor activation. This inhibition alters downstream signaling cascades, impacting cellular responses such as neurotransmitter release and gene expression. M35's kinetic profile reveals a rapid onset of action, with a notable affinity for specific receptor subtypes, enhancing its effectiveness in modulating galanin-mediated pathways.

M40

143896-17-7sc-391323
sc-391323A
0.5 mg
1 mg
$209.00
$355.00
(0)

M40 acts as a selective galr inhibitor through its ability to form stable complexes with galanin receptors, preventing ligand-induced conformational changes essential for receptor activation. Its unique molecular architecture facilitates strong non-covalent interactions, enhancing binding affinity. The compound exhibits distinct reaction kinetics, characterized by a gradual dissociation rate, which allows for prolonged modulation of galanin signaling pathways, influencing various cellular processes.

Galantide

138579-66-5sc-500854
0.5 mg
$500.00
(0)

Galantide functions as a selective galanin receptor inhibitor, exhibiting unique binding dynamics that disrupt galanin signaling pathways. Its structural conformation allows for specific interactions with receptor sites, influencing downstream cellular responses. The compound's kinetic profile reveals a competitive inhibition mechanism, where it effectively modulates receptor activity. Additionally, Galantide's ability to alter conformational states of the receptor enhances our understanding of receptor-ligand interactions in neurobiology.